Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Leukemia|February 2, 2019
A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivityMuhammad Yassin, Nasma Aqaqe, Abed Alkader Yassin, et al.
American Journal of Hematology|March 3, 2018
T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationJonathan Canaani, Myriam Labopin, Xiao-Jun Huang, et al.
Cancer|March 19, 2021
Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Yener Koc, et al.
American Journal of Hematology|January 3, 2022
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantationArnon Nagler, Myriam Labopin, Charles Craddock, et al.
Blood|May 31, 2012
FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulationTomer Itkin, Aya Ludin, Ben Gradus, et al.
American Journal of Hematology|June 13, 2020
Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantationArnon Nagler, Myriam Labopin, Jonathan Canaani, et al.
Bone Marrow Transplantation|February 2, 2022
Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMTArnon Nagler, Myriam Labopin, Xiao-Jun Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2019
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationOlle Ringdén, Ariane Boumendil, Myriam Labopin, et al.
American Journal of Hematology|June 15, 2017
Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSandra Eder, Jonathan Canaani, Eric Beohou, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 2018
Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Michael Potter, et al.
Pageof 6